PCMC
GILD icon

Planning Capital Management Corporation’s Gilead Sciences GILD Stock Holding History

Planning Capital Management Corporation’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$11.6K Buy
139
+69
+99% +$5.26K 0.01% 413
2024
Q2 		$4.8K Hold
70
– – ﹤0.01% 465
2024
Q1 		$5.13K Sell
70
-52
-43% -$4K ﹤0.01% 475
2023
Q4 		$9.88K Buy
+122
New +$9.49K 0.01% 419

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Planning Capital Management Corporation's GILD Position: Q3 2024 in Review

Planning Capital Management Corporation increased its Gilead Sciences (GILD) stake by 99% in Q3 2024, buying an estimated $5.26K and bringing the position to 139 shares worth $11.6K. The position accounts for 0.01% of the portfolio, ranked #413.

Planning Capital Management Corporation first reported a position in GILD in Q4 2023 and has held it in 4 quarters since. 1,719 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Planning Capital Management Corporation held 139 shares of Gilead Sciences worth $11.6K as of Q3 2024.
  • Planning Capital Management Corporation bought 69 Gilead Sciences shares in Q3 2024, an estimated $5.26K.
  • Gilead Sciences made up 0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #413 holding.
  • Planning Capital Management Corporation first reported a position in Gilead Sciences in Q4 2023 and has held it in 4 quarters since.
  • 1,719 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.